Prescription drug · ANDA
Atomoxetine NDC 50090-6143
Atomoxetine hydrochloride 40 mg/1 · Capsule · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-6143-0 | 5009061430050090614300 | 30 CAPSULE in 1 BOTTLE (50090-6143-0)Marketed from Oct 4, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Atomoxetine
- Generic name (nonproprietary)
- atomoxetine
- Active ingredients
- Atomoxetine hydrochloride — 40 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202682
- Marketing start
- Listing expires
- Other FDA classes
- Norepinephrine Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 50090-6143_a726ffd7-e7bd-4005-8b8a-b4d9bb58b67fSPL ID a726ffd7-e7bd-4005-8b8a-b4d9bb58b67fSPL set ID 0782204e-56a3-4439-9fb8-194da9487049RxCUI 349594UNII 57WVB6I2W0
- Pharmacologic class
- Norepinephrine Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090614300followed by a unit qualifier and the quantityPackage 50090-6143-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Atomoxetine capsule is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). ( 1.1 ) 1.1 Attention-Deficit/Hyperactivity Disorder (ADHD) Atomoxetine capsule is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). The efficacy of atomoxetine capsules was established in seven clinical trials in outpatients with ADHD: four 6 to 9-week trials in pediatric patients (ages 6 to 18), two 10-week trial in adults, and one maintenance trial in pediatrics (ages 6 to 15) [see Clinical Studies ( 14 )]. 1.2 Diagnostic Considerations A diagnosis of ADHD (DSM-IV) implies the presence of hyperactive-impulsive or…
Excerpt only. Read the full label for complete information.
About NDC 50090-6143
- What is NDC 50090-6143?
- 50090-6143 is the product NDC for Atomoxetine, Atomoxetine hydrochloride 40 mg/1 capsule, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Atomoxetine.
- What is the active ingredient?
- Atomoxetine hydrochloride.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Atomoxetine?
- 108 other product NDCs are listed under this name. See all Atomoxetine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Atomoxetine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Atomoxetine | Atomoxetine hydrochloride 100 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-121 | 82619-0121-0182619-0121-02 |
| Atomoxetine | Atomoxetine hydrochloride 60 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-119 | 82619-0119-0182619-0119-02 |
| Atomoxetine | Atomoxetine hydrochloride 80 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-120 | 82619-0120-0182619-0120-02 |
| Atomoxetine | Atomoxetine hydrochloride 40 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-118 | 82619-0118-0182619-0118-02 |
| Atomoxetine | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-115 | 82619-0115-0182619-0115-02 |
| Atomoxetine | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-116 | 82619-0116-0182619-0116-02 |
| Atomoxetine | Atomoxetine hydrochloride 25 mg/1 | CapsuleOral | Creekwood Pharmaceuticals LLC | 82619-117 | 82619-0117-0182619-0117-02 |
| Atomoxetine | Atomoxetine hydrochloride 25 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-437 | 72603-0437-01 |
| Atomoxetine | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-435 | 72603-0435-01 |
| Atomoxetine | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-436 | 72603-0436-01 |
Other NDCs under ANDA 202682
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Atomoxetine | Atomoxetine hydrochloride 60 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-439 |
| Atomoxetine | Atomoxetine hydrochloride 80 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-440 |
| Atomoxetine | Atomoxetine hydrochloride 100 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-441 |
| Atomoxetine | Atomoxetine hydrochloride 80 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-6127 |
| Atomoxetine | Atomoxetine hydrochloride 100 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-6144 |
| Atomoxetine | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-714 |
| Atomoxetine | Atomoxetine hydrochloride 60 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-718 |
| Atomoxetine | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-715 |
| Atomoxetine | Atomoxetine hydrochloride 25 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-716 |
| Atomoxetine | Atomoxetine hydrochloride 40 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-717 |
| Atomoxetine | Atomoxetine hydrochloride 80 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-719 |
| Atomoxetine | Atomoxetine hydrochloride 100 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-720 |
| Atomoxetine | Atomoxetine hydrochloride 40 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-438 |
| Atomoxetine | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-435 |
| Atomoxetine | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-436 |
| Atomoxetine | Atomoxetine hydrochloride 25 mg/1 | CapsuleOral | NorthStar RxLLC | 72603-437 |